128 related articles for article (PubMed ID: 16619544)
1. Prognosis of cerebellar glioblastomas: correlation between prognosis and immunoreactivity for epidermal growth factor receptor compared with supratentorial glioblastomas.
Saito T; Hama S; Kajiwara Y; Sugiyama K; Yamasaki F; Arifin MT; Arita K; Kurisu K
Anticancer Res; 2006; 26(2B):1351-7. PubMed ID: 16619544
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.
Shinojima N; Tada K; Shiraishi S; Kamiryo T; Kochi M; Nakamura H; Makino K; Saya H; Hirano H; Kuratsu J; Oka K; Ishimaru Y; Ushio Y
Cancer Res; 2003 Oct; 63(20):6962-70. PubMed ID: 14583498
[TBL] [Abstract][Full Text] [Related]
3. Selective sensitivity to radiation of cerebral glioblastomas harboring p53 mutations.
Tada M; Matsumoto R; Iggo RD; Onimaru R; Shirato H; Sawamura Y; Shinohe Y
Cancer Res; 1998 May; 58(9):1793-7. PubMed ID: 9581814
[TBL] [Abstract][Full Text] [Related]
4. Outcome and prognostic factors in cerebellar glioblastoma multiforme in adults: a retrospective study from the Rare Cancer Network.
Weber DC; Miller RC; Villà S; Hanssens P; Baumert BG; Castadot P; Varlet P; Abacioglu U; Igdem S; Szutowicz E; Nishioka H; Hofer S; Rutz HP; Ozsahin M; Taghian A; Mirimanoff RO
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):179-86. PubMed ID: 16814953
[TBL] [Abstract][Full Text] [Related]
5. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
[TBL] [Abstract][Full Text] [Related]
6. Expression of p53, EGFR, pRb and bcl-2 proteins in pediatric glioblastoma multiforme: a study of 54 patients.
Ganigi PM; Santosh V; Anandh B; Chandramouli BA; Sastry Kolluri VR
Pediatr Neurosurg; 2005; 41(6):292-9. PubMed ID: 16293948
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical investigation of p53 and EGFR expression of oligodendrogliomas.
Broholm H; Bols B; Heegaard S; Braendstrup O
Clin Neuropathol; 1999; 18(4):176-80. PubMed ID: 10442459
[TBL] [Abstract][Full Text] [Related]
8. Adult cerebellar glioblastoma cases have different characteristics from supratentorial glioblastoma.
Utsuki S; Oka H; Miyajima Y; Kijima C; Yasui Y; Fujii K
Brain Tumor Pathol; 2012 Apr; 29(2):87-95. PubMed ID: 22076316
[TBL] [Abstract][Full Text] [Related]
9. Ki-67, p53 and epidermal growth factor receptor expression in early glottic cancer involving the anterior commissure treated with radiotherapy.
Ahmed WA; Suzuki K; Imaeda Y; Horibe Y
Auris Nasus Larynx; 2008 Jun; 35(2):213-9. PubMed ID: 17996416
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor mutation status and adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.
Suehisa H; Toyooka S; Hotta K; Uchida A; Soh J; Fujiwara Y; Matsuo K; Ouchida M; Takata M; Kiura K; Date H
J Clin Oncol; 2007 Sep; 25(25):3952-7. PubMed ID: 17761979
[TBL] [Abstract][Full Text] [Related]
11. Outcome and prognostic factors in adult cerebellar glioblastoma.
Babu R; Sharma R; Karikari IO; Owens TR; Friedman AH; Adamson C
J Clin Neurosci; 2013 Aug; 20(8):1117-21. PubMed ID: 23706183
[TBL] [Abstract][Full Text] [Related]
12. Comparison of survival between cerebellar and supratentorial glioblastoma patients: surveillance, epidemiology, and end results (SEER) analysis.
Jeswani S; Nuño M; Folkerts V; Mukherjee D; Black KL; Patil CG
Neurosurgery; 2013 Aug; 73(2):240-6; discussion 246; quiz 246. PubMed ID: 23615082
[TBL] [Abstract][Full Text] [Related]
13. Amplification of the epidermal growth factor receptor in astrocytic tumours by chromogenic in situ hybridization: association with clinicopathological features and patient survival.
Järvelä S; Helin H; Haapasalo J; Järvelä T; Junttila TT; Elenius K; Tanner M; Haapasalo H; Isola J
Neuropathol Appl Neurobiol; 2006 Aug; 32(4):441-50. PubMed ID: 16866989
[TBL] [Abstract][Full Text] [Related]
14. Non-pineal supratentorial primitive neuro-ectodermal tumors (sPNET) in teenagers and young adults: Time to reconsider cisplatin based chemotherapy after cranio-spinal irradiation?
Biswas S; Burke A; Cherian S; Williams D; Nicholson J; Horan G; Jefferies S; Williams M; Earl HM; Burnet NG; Hatcher H
Pediatr Blood Cancer; 2009 Jul; 52(7):796-803. PubMed ID: 19202566
[TBL] [Abstract][Full Text] [Related]
15. EGFR as paradoxical predictor of chemosensitivity and outcome among triple-negative breast cancer.
Nogi H; Kobayashi T; Suzuki M; Tabei I; Kawase K; Toriumi Y; Fukushima H; Uchida K
Oncol Rep; 2009 Feb; 21(2):413-7. PubMed ID: 19148516
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of supratentorial glioma in adults by intra-arterial HECNU. Experience of the Pitié-Salpétrière group].
Poisson M; Chiras J; Fauchon F; Delattre JY
Rev Neurol (Paris); 1992; 148(6-7):441-7. PubMed ID: 1448664
[TBL] [Abstract][Full Text] [Related]
17. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M
Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071
[TBL] [Abstract][Full Text] [Related]
18. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer.
Dihge L; Bendahl PO; Grabau D; Isola J; Lövgren K; Rydén L; Fernö M
Breast Cancer Res Treat; 2008 May; 109(2):255-62. PubMed ID: 17636398
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.
Aghi M; Gaviani P; Henson JW; Batchelor TT; Louis DN; Barker FG
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8600-5. PubMed ID: 16361543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
